Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the Chinese Rheumatism Data Center (CRDC)-Supplementary materials

This document provides the supplementary materials for the article entitled “Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the Chinese Rheumatism Data Center (CRDC)”. The supplementary materials include multiple figures and tables that support the findings of the main manuscript.本文档为题为《托法替布治疗系统性硬化症患者皮肤硬化进展的真实世界疗效与安全性：基于中国风湿病数据中心（Chinese Rheumatism Data Center, CRDC）全国多中心数据的分析》的论文提供补充材料。本补充材料包含多幅图表，用以支撑主论文的研究结论。